VRDN logo

Viridian Therapeutics, Inc. (VRDN) Net Income

Annual Net Income:

-$208.56M+$29.17M(+12.27%)
December 31, 2024

Summary

  • As of today, VRDN annual net profit is -$208.56 million, with the most recent change of +$29.17 million (+12.27%) on December 31, 2024.
  • During the last 3 years, VRDN annual net income has fallen by -$129.15 million (-162.63%).
  • VRDN annual net income is now -9556.90% below its all-time high of -$2.16 million, reached on December 31, 2013.

Performance

VRDN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNincome statement metrics

Quarterly Net Income:

-$100.73M-$13.82M(-15.90%)
June 30, 2025

Summary

  • As of today, VRDN quarterly net profit is -$100.73 million, with the most recent change of -$13.82 million (-15.90%) on June 30, 2025.
  • Over the past year, VRDN quarterly net income has dropped by -$35.74 million (-54.99%).
  • VRDN quarterly net income is now -49474.31% below its all-time high of -$203.20 thousand, reached on December 31, 2013.

Performance

VRDN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNincome statement metrics

TTM Net Income:

-$328.98M-$35.74M(-12.19%)
June 30, 2025

Summary

  • As of today, VRDN TTM net profit is -$328.98 million, with the most recent change of -$35.74 million (-12.19%) on June 30, 2025.
  • Over the past year, VRDN TTM net income has dropped by -$100.93 million (-44.26%).
  • VRDN TTM net income is now -35354.68% below its all-time high of -$927.90 thousand, reached on December 31, 2013.

Performance

VRDN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

VRDN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+12.3%-55.0%-44.3%
3Y3 Years-162.6%-241.6%-235.1%
5Y5 Years-398.1%-1465.4%-993.3%

VRDN Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-162.6%+12.3%-248.5%at low-191.1%at low
5Y5-Year-398.1%+12.3%-1733.5%at low-993.3%at low
All-TimeAll-Time-9556.9%+12.3%>-9999.0%at low>-9999.0%at low

VRDN Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$100.73M(-15.9%)
-$328.98M(-12.2%)
Mar 2025
-
-$86.91M(-34.4%)
-$293.24M(-15.1%)
Dec 2024
-$208.56M(+12.3%)
-$64.65M(+15.7%)
-$254.87M(+0.9%)
Sep 2024
-
-$76.69M(-18.0%)
-$257.08M(-12.7%)
Jun 2024
-
-$64.99M(-33.9%)
-$228.06M(-4.6%)
Mar 2024
-
-$48.54M(+27.4%)
-$218.13M(+8.2%)
Dec 2023
-$237.73M(-83.0%)
-$66.86M(-40.3%)
-$237.73M(-9.7%)
Sep 2023
-
-$47.66M(+13.4%)
-$216.66M(-9.5%)
Jun 2023
-
-$55.06M(+19.2%)
-$197.90M(-14.8%)
Mar 2023
-
-$68.15M(-48.9%)
-$172.33M(-32.7%)
Dec 2022
-$129.87M(-63.5%)
-$45.78M(-58.4%)
-$129.87M(-14.9%)
Sep 2022
-
-$28.91M(+2.0%)
-$113.03M(-15.1%)
Jun 2022
-
-$29.49M(-14.8%)
-$98.17M(-13.3%)
Mar 2022
-
-$25.69M(+11.2%)
-$86.65M(-9.1%)
Dec 2021
-$79.41M(+28.3%)
-$28.95M(-106.1%)
-$79.41M(+43.8%)
Sep 2021
-
-$14.04M(+21.8%)
-$141.21M(-6.4%)
Jun 2021
-
-$17.96M(+2.7%)
-$132.66M(-9.5%)
Mar 2021
-
-$18.46M(+79.7%)
-$121.13M(-9.4%)
Dec 2020
-$110.72M(-164.4%)
-$90.74M(-1551.7%)
-$110.72M(-267.9%)
Sep 2020
-
-$5.49M(+14.6%)
-$30.09M(+16.0%)
Jun 2020
-
-$6.43M(+20.0%)
-$35.83M(+6.4%)
Mar 2020
-
-$8.04M(+20.5%)
-$38.29M(+8.6%)
Dec 2019
-$41.87M
-$10.12M(+9.9%)
-$41.87M(+0.5%)
Sep 2019
-
-$11.23M(-26.2%)
-$42.07M(-5.6%)
Jun 2019
-
-$8.90M(+23.5%)
-$39.85M(-0.5%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$11.63M(-12.7%)
-$39.67M(-21.3%)
Dec 2018
-$32.70M(-23.3%)
-$10.32M(-14.5%)
-$32.70M(-13.7%)
Sep 2018
-
-$9.01M(-3.4%)
-$28.77M(-12.4%)
Jun 2018
-
-$8.71M(-87.0%)
-$25.59M(-5.8%)
Mar 2018
-
-$4.66M(+27.0%)
-$24.19M(+8.8%)
Dec 2017
-$26.52M(-53.1%)
-$6.39M(-9.5%)
-$26.52M(-1.5%)
Sep 2017
-
-$5.83M(+20.2%)
-$26.12M(-6.8%)
Jun 2017
-
-$7.31M(-4.7%)
-$24.45M(-24.5%)
Mar 2017
-
-$6.99M(-16.7%)
-$19.64M(-27.4%)
Dec 2016
-$17.32M(-52.9%)
-$5.99M(-43.7%)
-$15.42M(-24.2%)
Sep 2016
-
-$4.17M(-66.2%)
-$12.41M(-8.9%)
Jun 2016
-
-$2.51M(+9.1%)
-$11.40M(+0.5%)
Mar 2016
-
-$2.76M(+7.4%)
-$11.45M(-1.1%)
Dec 2015
-$11.33M(-43.6%)
-$2.98M(+5.5%)
-$11.33M(-6.8%)
Sep 2015
-
-$3.15M(-23.0%)
-$10.61M(-16.7%)
Jun 2015
-
-$2.56M(+2.7%)
-$9.09M(+7.4%)
Mar 2015
-
-$2.63M(-16.6%)
-$9.82M(-36.7%)
Dec 2014
-$7.89M(-265.3%)
-$2.26M(-37.9%)
-$7.18M(-40.1%)
Sep 2014
-
-$1.64M(+50.2%)
-$5.13M(-21.6%)
Jun 2014
-
-$3.29M(-1518.6%)
-$4.22M(-354.4%)
Dec 2013
-$2.16M(+61.6%)
-$203.20K(+72.0%)
-$927.90K(+35.3%)
Sep 2013
-
-$724.70K(-2.3%)
-$1.43M(+49.4%)
Dec 2012
-$5.62M
-
-
Dec 2012
-
-$708.40K(+66.6%)
-$2.83M(-33.4%)
Sep 2012
-
-$2.12M
-$2.12M

FAQ

  • What is Viridian Therapeutics, Inc. annual net profit?
  • What is the all-time high annual net income for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. annual net income year-on-year change?
  • What is Viridian Therapeutics, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Viridian Therapeutics, Inc. TTM net profit?
  • What is the all-time high TTM net income for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. TTM net income year-on-year change?

What is Viridian Therapeutics, Inc. annual net profit?

The current annual net income of VRDN is -$208.56M

What is the all-time high annual net income for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high annual net profit is -$2.16M

What is Viridian Therapeutics, Inc. annual net income year-on-year change?

Over the past year, VRDN annual net profit has changed by +$29.17M (+12.27%)

What is Viridian Therapeutics, Inc. quarterly net profit?

The current quarterly net income of VRDN is -$100.73M

What is the all-time high quarterly net income for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high quarterly net profit is -$203.20K

What is Viridian Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, VRDN quarterly net profit has changed by -$35.74M (-54.99%)

What is Viridian Therapeutics, Inc. TTM net profit?

The current TTM net income of VRDN is -$328.98M

What is the all-time high TTM net income for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high TTM net profit is -$927.90K

What is Viridian Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, VRDN TTM net profit has changed by -$100.93M (-44.26%)
On this page